TH!S W!LL BL0W Y0UR M!ND
Populations at risk for, and consequences of, vitamin A deficiency 2.2.1 Definition of vitamin A deficiency VAD is not easily defined. WHO defines it as tissue concentrations of vitamin A low enough to have adverse health consequences even if there is no evidence of clinical xerophthalmia (16). In addition to the specific signs and symptoms of xerophthalmia and the risk of irreversible blindness, nonspecific symptoms include increased morbidity and mortality, poor reproductive health, increased risk of anaemia, and contributions to slowed growth and development. However, these nonspecific adverse effects may be caused by other nutrient deficits as well, making it difficult to attribute non-ocular symptoms specifically to VAD in the absence of biochemical measurements reflective of vitamin A status. 2.2.2 Geographic distribution and magnitude In 1995, WHO estimated the global distribution of VAD (Table 2.1) and categorized countries according to the seriousness of VAD as a public health...